NASDAQ: VBIO Valion Bio, Inc. 8-K

Valion Bio reports Q1 2026 financial results in routine earnings disclosure

Filed May 14, 2026 · Period ending May 14, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade VBIO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 4:24 PM